A Randomized, Open-label, Active-controlled Study to Evaluate Social Functioning of Long Acting Injectable Risperidone and Oral Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder.
Phase of Trial: Phase IV
Latest Information Update: 06 May 2014
At a glance
- Drugs Risperidone (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen
- 09 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Sep 2010 Actual initiation date (Dec 2007) added as reported by ClinicalTrials.gov.